- Home
- AZN vs ABT Comparison
AZN vs ABT Comparison
Compare AZN & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZN
- ABT
- Stock Information
- Founded
- AZN 1992
- ABT 1888
- Country
- AZN United Kingdom
- ABT United States
- Employees
- AZN N/A
- ABT N/A
- Industry
- AZN Biotechnology: Pharmaceutical Preparations
- ABT Medical/Dental Instruments
- Sector
- AZN Health Care
- ABT Health Care
- Exchange
- AZN Nasdaq
- ABT Nasdaq
- Market Cap
- AZN 233.8B
- ABT 221.0B
- IPO Year
- AZN 1993
- ABT N/A
- Fundamental
- Price
- AZN $73.79
- ABT $130.82
- Analyst Decision
- AZN Strong Buy
- ABT Buy
- Analyst Count
- AZN 7
- ABT 18
- Target Price
- AZN $89.75
- ABT $136.06
- AVG Volume (30 Days)
- AZN 5.3M
- ABT 7.5M
- Earning Date
- AZN 04-29-2025
- ABT 04-16-2025
- Dividend Yield
- AZN 2.09%
- ABT 1.80%
- EPS Growth
- AZN 18.11
- ABT 134.36
- EPS
- AZN 4.50
- ABT 7.64
- Revenue
- AZN $54,073,000,000.00
- ABT $41,950,000,000.00
- Revenue This Year
- AZN $8.64
- ABT $6.72
- Revenue Next Year
- AZN $6.11
- ABT $7.45
- P/E Ratio
- AZN $32.57
- ABT $17.12
- Revenue Growth
- AZN 18.04
- ABT 4.59
- 52 Week Low
- AZN $62.75
- ABT $99.71
- 52 Week High
- AZN $87.68
- ABT $141.23
- Technical
- Relative Strength Index (RSI)
- AZN 45.57
- ABT 52.64
- Support Level
- AZN $71.82
- ABT $124.50
- Resistance Level
- AZN $75.12
- ABT $128.79
- Average True Range (ATR)
- AZN 1.04
- ABT 2.83
- MACD
- AZN -0.61
- ABT -0.20
- Stochastic Oscillator
- AZN 33.16
- ABT 50.32
Stock Price Comparison Chart: AZN vs ABT
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.